This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its quinazolinone core structure is particularly valuable in the development of inhibitors targeting specific enzymes, such as kinases, which play a critical role in cellular signaling pathways. Researchers leverage its trifluoromethyl group to enhance the metabolic stability and binding affinity of potential drug candidates. Additionally, it has been explored in the design of compounds with potential anticancer, anti-inflammatory, and antimicrobial properties. Its versatility makes it a valuable building block in drug discovery and development processes.